Lv2
140 积分 2026-01-28 加入
Talquetamab in patients with relapsed/refractory multiple myeloma: 3-year follow-up of the phase 1/2 MonumenTAL-1 study
5小时前
求助中
Vobramitamab duocarmazine, an anti–B7‐H3 antibody–drug conjugate, in patients with advanced solid tumors: Final results of a phase 1 cohort expansion
18小时前
已完结
Promising Therapeutic Activity of 177Lu-PSMA-617 in Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer
1天前
已完结
CN-105 in Participants with Acute SupraTentorial IntraCerebral Hemorrhage (CATCH) Trial
27天前
已完结
Novel clinical risk stratification and treatment strategies in relapsed/refractory peripheral T-cell lymphoma
28天前
已完结
Lipid metabolism in homeostasis and disease
1个月前
已完结
Plozasiran, an RNA Interference Agent Targeting APOC3, for Mixed Hyperlipidemia
1个月前
已完结
Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome
1个月前
已完结
Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia
1个月前
已完结
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
1个月前
已完结
皖公网安备34019202002308
